Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033435813> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2033435813 endingPage "1859" @default.
- W2033435813 startingPage "1855" @default.
- W2033435813 abstract "AGI-1067 is a derivative of probucol that is a promising new development for the treatment of restenosis and possibly atherosclerosis. In monkeys fed a high-fat diet for 1 year, AGI-1067 prevented the development of atherosclerosis. In these monkeys, AGI-1067 lowered plasma levels of low-density lipoprotein (LDL)-cholesterol and, in contrast to probucol, was capable of increasing high-density lipoprotein (HDL)-cholesterol levels. Although AGI1067 did not have marked lipid-lowering effects in two transgenic mouse models (the LDL-receptor-deficient and apolipoprotein-E-deficient models) fed a high-fat chow, it decreased the atherosclerotic lesion area in the aorta. In a mouse model of acute inflammation, the mRNA for the pro-inflammatory vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 was upregulated and this was inhibited by AGI-1067. AGI-1067 inhibited the TNF-alpha induction of redox-sensitive inflammatory proteins, vascular cell adhesion molecule-1, monocyte chemoattractant protein-1 and Eselectin, in cell culture. In addition, AGI-1067 is an antioxidant. In the Canadian Antioxidant Restenosis Trial (CART-1) of AGI-1067 in percutaneous coronary interventions, AGI-1067 had no effect on LDL-cholesterol but lowered HDL-cholesterol. At 6 months follow up, the lumen area of the percutaneous coronary interventions segments was greater in patients treated with AGI1067 than in untreated patients. Restenosis rates were 37.5% in the placebo group and 26% in the AGI-1067 group. The lumen area of reference segments was reduced in the placebo group but increased with the higher doses of AGI1067. Unlike probucol, AGI-1067 did not alter QTc interval." @default.
- W2033435813 created "2016-06-24" @default.
- W2033435813 creator A5071085963 @default.
- W2033435813 date "2003-11-01" @default.
- W2033435813 modified "2023-09-25" @default.
- W2033435813 title "Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth" @default.
- W2033435813 cites W1973429676 @default.
- W2033435813 cites W1994492137 @default.
- W2033435813 cites W2045096999 @default.
- W2033435813 cites W2047604586 @default.
- W2033435813 cites W2078473682 @default.
- W2033435813 cites W2097006357 @default.
- W2033435813 cites W2100234224 @default.
- W2033435813 cites W2106410529 @default.
- W2033435813 cites W2111779767 @default.
- W2033435813 cites W2121348838 @default.
- W2033435813 cites W2129380027 @default.
- W2033435813 cites W2131900346 @default.
- W2033435813 cites W2139018594 @default.
- W2033435813 cites W2155372623 @default.
- W2033435813 cites W2163951996 @default.
- W2033435813 cites W2330609598 @default.
- W2033435813 doi "https://doi.org/10.1517/13543784.12.11.1855" @default.
- W2033435813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14585060" @default.
- W2033435813 hasPublicationYear "2003" @default.
- W2033435813 type Work @default.
- W2033435813 sameAs 2033435813 @default.
- W2033435813 citedByCount "4" @default.
- W2033435813 countsByYear W20334358132022 @default.
- W2033435813 countsByYear W20334358132023 @default.
- W2033435813 crossrefType "journal-article" @default.
- W2033435813 hasAuthorship W2033435813A5071085963 @default.
- W2033435813 hasConcept C126322002 @default.
- W2033435813 hasConcept C134018914 @default.
- W2033435813 hasConcept C2776167589 @default.
- W2033435813 hasConcept C2778163477 @default.
- W2033435813 hasConcept C2778283817 @default.
- W2033435813 hasConcept C2778583881 @default.
- W2033435813 hasConcept C2780072125 @default.
- W2033435813 hasConcept C71924100 @default.
- W2033435813 hasConceptScore W2033435813C126322002 @default.
- W2033435813 hasConceptScore W2033435813C134018914 @default.
- W2033435813 hasConceptScore W2033435813C2776167589 @default.
- W2033435813 hasConceptScore W2033435813C2778163477 @default.
- W2033435813 hasConceptScore W2033435813C2778283817 @default.
- W2033435813 hasConceptScore W2033435813C2778583881 @default.
- W2033435813 hasConceptScore W2033435813C2780072125 @default.
- W2033435813 hasConceptScore W2033435813C71924100 @default.
- W2033435813 hasIssue "11" @default.
- W2033435813 hasLocation W20334358131 @default.
- W2033435813 hasLocation W20334358132 @default.
- W2033435813 hasOpenAccess W2033435813 @default.
- W2033435813 hasPrimaryLocation W20334358131 @default.
- W2033435813 hasRelatedWork W1972175381 @default.
- W2033435813 hasRelatedWork W1994826758 @default.
- W2033435813 hasRelatedWork W2005998106 @default.
- W2033435813 hasRelatedWork W2019813684 @default.
- W2033435813 hasRelatedWork W2032958076 @default.
- W2033435813 hasRelatedWork W2075372262 @default.
- W2033435813 hasRelatedWork W2108336629 @default.
- W2033435813 hasRelatedWork W2142791464 @default.
- W2033435813 hasRelatedWork W2167322121 @default.
- W2033435813 hasRelatedWork W2168843442 @default.
- W2033435813 hasVolume "12" @default.
- W2033435813 isParatext "false" @default.
- W2033435813 isRetracted "false" @default.
- W2033435813 magId "2033435813" @default.
- W2033435813 workType "article" @default.